Search

Your search keyword '"Jones, Terry C."' showing total 252 results

Search Constraints

Start Over You searched for: Author "Jones, Terry C." Remove constraint Author: "Jones, Terry C."
252 results on '"Jones, Terry C."'

Search Results

1. Divergent Genotype of Hepatitis A Virus in Alpacas, Bolivia, 2019

3. Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron

4. Defining the risk of SARS-CoV-2 variants on immune protection

5. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01

6. US National Institutes of Health Prioritization of SARS-CoV-2 Variants

8. Human monkeypox – After 40 years, an unintended consequence of smallpox eradication

9. Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies

10. Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2

11. Genetic characterization of varicella-zoster and HIV-1 viruses from the cerebrospinal fluid of a co-infected encephalitic patient, Ghana

13. Detection of two alphaviruses: Middelburg virus and Sindbis virus from enzootic amplification cycles in southwestern Uganda.

14. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells

15. Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays

16. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01

18. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany

19. Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021

20. Virological assessment of hospitalized patients with COVID-2019

21. The landscape of ancient human pathogens in Eurasia from the Stone Age to historical times

22. Mapping SARS-CoV-2 antigenic relationships and serological responses

23. The International Virus Bioinformatics Meeting 2023

24. Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera

25. Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection

26. Ancient human parvovirus B19 in Eurasia reveals its long-term association with humans

27. Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants

29. Ancient hepatitis B viruses from the Bronze Age to the Medieval period

30. Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection

31. The International Virus Bioinformatics Meeting 2023

32. The International Virus Bioinformatics Meeting 2023

34. Non-structural genes of novel lemur adenoviruses reveal codivergence of virus and host

36. SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression

37. A Multicenter Clinical Diagnostic Accuracy Study of SureStatus, an Affordable, WHO Emergency Use-Listed, Rapid, Point-Of-Care Antigen-Detecting Diagnostic Test for SARS-CoV-2

38. Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonism

39. Genetic variability, including gene duplication and deletion, in early sequences from the 2022 European monkeypox outbreak

40. 90K/LGALS3BP Expression is Upregulated in COVID-19 but Does Not Restrict SARS-CoV-2 Infection

41. Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2

42. Defining the risk of SARS-CoV-2 variants on immune protection

44. sj-docx-6-msj-10.1177_13524585221094478 – Supplemental material for Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis

45. Additional file 1 of Genetic characterization of varicella-zoster and HIV-1 viruses from the cerebrospinal fluid of a co-infected encephalitic patient, Ghana

46. sj-doc-5-msj-10.1177_13524585221094478 – Supplemental material for Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis

47. sj-doc-1-msj-10.1177_13524585221094478 – Supplemental material for Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis

48. The Global Circulation of Seasonal Influenza a (H3N2) Viruses

49. SARS-CoV-2 Variant of Concern B.1.1.7: Diagnostic Sensitivity of Three Antigen-Detecting Rapid Tests

50. Mapping SARS-CoV-2 antigenic relationships and serological responses

Catalog

Books, media, physical & digital resources